Large studies encompassing thousands of people have since shown that following the MIND diet corresponds with better ...

In the quiet corners of our local markets, tucked among bags of dried barks, aromatic leaves, and citrus fruits, lies a sophisticated pharmacological toolkit often overlooked for synthetic ...

She gained weight after welcoming her son Reggie in September 2018 and shed the pounds once again with a combination of ...

A substantial percentage of adults with gout attribute their condition to lifestyle factors, which may lead to worse health outcomes and poorer SU control.

Sobi has hit the acquisition trail with a deal to buy Arthrosi Therapeutics for up to $1.5 billion, adding a drug in late-stage clinical testing for gout. The deal, which includes a sizeable $950 ...

XORTX Therapeutics Inc. ("XORTX" or the "Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...

Sheela Das, a 40-year-old woman from Dollygunj, Andaman and Nicobar Islands, had been suffering from arthritis and gout for ...

An Ayurvedic centre in Haridwar claims to have treated a 40-year-old woman suffering from severe arthritis and gout through ...

The post Healthy aging in the New Year: What AsAm seniors can learn appeared first on AsAmNews. There’s something about ...

High uric acid, or hyperuricemia, quietly affects countless people-and often sparks painful gout attacks or kidney troubles down the line. A new pilot.

Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a potential value of $1.5 billion from Swedish biopharma Sobi. Under the deal ...

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in ...